Billionaire Stanley Druckenmiller Sold His Fund's Stakes in Nvidia and Palantir, and Has Piled Into These 2 Phenomenal Stocks for 4 Straight Quarters

Core Insights - Duquesne Family Office's billionaire boss, Stanley Druckenmiller, has shifted investments from high-flying AI stocks like Nvidia and Palantir to Taiwan Semiconductor Manufacturing Company (TSMC) and Teva Pharmaceutical Industries, indicating a strategic pivot towards more stable sectors [1][14]. Investment Strategy - Druckenmiller has opened 45 new positions and adjusted existing holdings over the last four 13Fs, with significant changes in his portfolio [4]. - The decision to sell all shares of Nvidia and Palantir reflects a profit-taking strategy amid their substantial price increases, with Nvidia's shares rising nearly 1,200% and Palantir's by over 2,800% since the beginning of 2023 [6][9]. Company Performance - Nvidia is recognized as a leading supplier of AI GPUs, with a current market valuation approaching $5 trillion, while Palantir's software platforms are integral to government and business operations [7][8]. - Despite their competitive advantages, Druckenmiller's exit from these positions suggests concerns over potential market corrections and high valuations, with Nvidia's price-to-sales (P/S) ratio nearing 30 and Palantir's at an extraordinary 137 [13]. New Investments - TSMC has become a key holding for Duquesne, driven by its role in AI chip production and its diversified product offerings beyond AI, making it more resilient to market fluctuations [15][16]. - Teva Pharmaceutical has seen a turnaround after addressing litigation issues and reducing debt, with a focus on novel drug development, positioning it as a strong investment with a low forward price-to-earnings ratio [17][18][22].